---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009828"
form_type: "8-K"
ticker: "CARL"
cik: "0001794546"
company_name: "CARLSMED, INC."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:55:10.202880+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Carlsmed reports Q4 revenue ~$15.2M (+61% YoY); FY2025 ~$50.5M (+86% YoY)

## Summary
- Preliminary Q4 2025 revenue of ~$15.2M, 61% increase over Q4 2024.
- Full-year 2025 revenue of ~$50.5M, 86% increase over 2024.
- Added 101 new surgeon users in 2025, a 61% increase in user base.
- Launched aprevo® cervical; early surgeon feedback encouraging.
- CEO cites transformational year; company focused on operational excellence for 2026.

## SEC filing metadata
- accession: 0001193125-26-009828
- form_type: 8-K
- ticker: CARL
- cik: 0001794546
- company_name: CARLSMED, INC.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1794546/000119312526009828/0001193125-26-009828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1794546/000119312526009828/carl-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009828
- JSON: https://secwatch.observer/filing/0001193125-26-009828.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.